Catalyst Wire Dossier Catalyst Wire Dossier

Intradermal Microbotulinum Toxin

botulinum toxin type A
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Intradermal Microbotulinum Toxin, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement [NA]

See pricing